Trials / Conditions / Richter Transformation
Richter Transformation
7 registered clinical trials studyying Richter Transformation — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas NCT07168486 | University of Maryland, Baltimore | Phase 1 |
| Active Not Recruiting | A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies NCT05828589 | BeOne Medicines | Phase 1 |
| Recruiting | A Study of NX-1607 in Adults With Advanced Malignancies NCT05107674 | Nurix Therapeutics, Inc. | Phase 1 |
| Unknown | R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL NCT04992377 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Recruiting | Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CM NCT04771572 | Newave Pharmaceutical Inc | Phase 1 |
| Recruiting | DALY II USA/ MB-CART2019.1 for DLBCL NCT04792489 | Miltenyi Biomedicine GmbH | Phase 2 |
| Recruiting | Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment with or Without Sonrotoclax for Patients with NCT04271956 | German CLL Study Group | Phase 2 |